38 results
POS AM
ADIL
Adial Pharmaceuticals Inc
24 Jun 22
Prospectus update (post-effective amendment)
5:11pm
may result in unexpected costs, or to discontinue the clinical trials altogether;
delays in necessary interactions with local regulators, ethics … with the Company’s Code of Business Conduct and Ethics, investigating alleged breaches or violations thereof and enforcing its provisions.
Special Committee
During
POS AM
2uc 1tkbwhb
24 Jun 22
Prospectus update (post-effective amendment)
5:02pm
POS AM
vhqzc90gi4o9hvoj7jeu
6 Apr 21
Prospectus update (post-effective amendment)
12:00am
POS AM
v8f1s8ypgg5
6 Apr 21
Prospectus update (post-effective amendment)
12:00am
424B3
csxfzbh
13 Jul 20
Prospectus supplement
4:46pm
8-K
EX-99.1
ty0 z2cyxxacpr3o
11 Jun 20
Adial Pharmaceuticals Announces Approval to Commence Landmark ONWARD™ Pivotal Phase 3 Trial in Poland
11:58am
424B5
ut4urz en0
10 Jun 20
Prospectus supplement for primary offering
4:14pm
424B3
dmqdpko ne3bjlc5m6
22 May 20
Prospectus supplement
4:30pm
424B3
woqx2rpmv5h 90
22 May 20
Prospectus supplement
4:28pm